Cruz-Correa, M. R., Han, S., Malik, R. A., Su, H. Y., Eynde, M. V. D., Oberstein, P. E., Yuan, Y., Moreno, V., Pietrantonio, F., Chen, E. X., Raghav, K. P. S., Chowdhury, S., Lu, X., Bhattacharya, R., Barala, P., Monge, C., Sethi, S. N., Chandana, S. R. (2026). Antitumor activity of amivantamab by consensus molecular subtypes in
                    <i>RAS</i>
                    /
                    <i>BRAF</i>
                    wild-type metastatic colorectal cancer: Secondary analyses from the phase 1b/2 OrigAMI-1 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3548